Whalegun
List

Notice of Request for Public Comments on Section 232 National Security Investigation of Imports of Pharmaceuticals and Pharmaceutical Ingredients

BIS ruleInvestigation openedFederal Register 25/04/16Open the original

Summary

The Secretary of Commerce opened a Section 232 investigation on April 1, 2025, into imports of pharmaceuticals and pharmaceutical ingredients, including finished drugs and active ingredients, and their derivative products. BIS requests comments by May 7, 2025.

By industry

Day by day after the announcement

Healthcare & Drug Pricing stocks and the S&P 500 after the announcement, cumulative %
Healthcare & Drug Pricing stocks and the S&P 500 after the announcement, cumulative %
DayHealthcare & Drug Pricing stocksS&P 500
25/04/150.0%0.0%
25/04/16−1.1%−1.9%
25/04/17−1.6%−1.3%
25/04/21−3.5%−4.0%
25/04/22−2.3%+0.3%
25/04/23−1.9%+0.3%
25/04/24−1.3%+2.6%
25/04/25−0.8%+3.0%
25/04/28−0.3%+2.8%
25/04/29+0.5%+3.3%
25/04/30+1.7%+4.3%
25/05/01−0.1%+4.2%
25/05/02+0.6%+5.9%
25/05/05+0.4%+5.2%
25/05/06−2.1%+5.2%
25/05/07−1.4%+4.8%
25/05/08−3.0%+5.5%
25/05/09−4.1%+5.5%
25/05/12−2.8%+9.0%
25/05/13−6.0%+9.7%
25/05/14−8.5%+9.7%

Korean stocks in these industries

  • Samsung Biologics 207940
  • Celltrion 068270
  • SK Biopharmaceuticals 326030

Trades in these industries around the announcement

Members' and insiders' trades in the industries' stocks, 30 days before to 30 days after.

  • Stephen J. Hemsley

    BuyUnitedhealth Group

    $25M

    Filed 25/05/16

  • John F. Rex

    BuyUnitedhealth Group

    $5M

    Filed 25/05/16

  • Kristen Gil

    BuyUnitedhealth Group

    $1M

    Filed 25/05/16

  • Timothy Patrick Flynn

    BuyUnitedhealth Group

    $491.8K

    Filed 25/05/16

  • John H. Noseworthy

    BuyUnitedhealth Group

    $93.6K

    Filed 25/05/16

  • Samit Hirawat

    BuyBristol Myers Squibb

    $202.2K

    Filed 25/04/29

  • Julia Letlow

    BuyUnitedhealth Group

    $1K–$15K

    Reported 01/13

  • Larry Robbins

    SellCVS Health

    $113.2M

    Filed 25/05/06

  • Larry Robbins

    SellCVS Health

    $82.7M

    Filed 25/05/06

  • Jeffrey Ryan Stewart

    SellAbbVie

    $7M

    Filed 25/04/02

  • Jeffrey Ryan Stewart

    SellAbbVie

    $5.4M

    Filed 25/04/02

  • Julia Letlow

    Full saleCigna Group

    $1K–$15K

    Reported 01/13

  • Julia Letlow

    BuyAbbVie

    $1K–$15K

    Reported 01/13

  • John Boozman

    BuyUnitedhealth Group

    $1K–$15K

    Reported 25/05/14

  • Larry Robbins

    SellCVS Health

    $26M

    Filed 25/05/06

  • Mark Kaye

    SellElevance Health

    $1.9M

    Filed 25/04/25

  • Larry Robbins

    SellCVS Health

    $15.2M

    Filed 25/05/06

  • Tommy Tuberville

    Full saleELI Lilly

    $15K–$50K

    Reported 25/05/15

  • Tommy Tuberville

    Full saleAmgen

    $15K–$50K

    Reported 25/05/15

  • Larry Robbins

    SellCVS Health

    $10M

    Filed 25/05/06

Notice of Request for Public Comments on Section 232 National Security Investigation of Imports of Pharmaceuticals and Pharmaceutical Ingredients | Whalegun